German biotech SME applying enzymatic chemistry to develop sustainable bio-based binders and resins for wood panel and furniture manufacturing.
JENABIOS is a Jena-based biotechnology SME specializing in enzyme-driven chemistry for producing bio-based materials and chemical precursors. Their core capability is applying enzymatic oxidation and oxyfunctionalization reactions to convert renewable feedstocks into functional industrial chemicals. In practice, this means they develop the biochemical processes by which plant-derived raw materials are transformed into resins, binders, and adhesive systems that can replace petroleum-based equivalents in wood panels and furniture manufacturing. They sit at the intersection of industrial biotechnology and sustainable materials — a niche position with direct application in green manufacturing supply chains.
EnzOx2 (2016–2019) was dedicated entirely to developing new enzymatic oxidation technologies for bio-based product streams, establishing this as JENABIOS's foundational technical capability.
SusBind (2018–2022) focused specifically on developing sustainable bio-binder systems for wood-based panels, directly applying enzyme-derived bio precursors to industrial adhesive formulations.
SusBind targeted wood-based panel boards and the furniture sector as the end-use market for their bio-derived binder chemistry.
Both projects were funded under bio-economy schemes (BBI-RIA and RIA under P3-FOOD/bioeconomy pillar), reflecting consistent positioning within the circular bio-based materials value chain.
JENABIOS entered H2020 with a broad enzymatic technology focus — EnzOx2 (2016–2019) explored oxyfunctionalization at a platform level without specifying a target application sector. By their second project, SusBind (2018–2022), the focus had sharpened considerably: the same enzyme chemistry is now pointed at a very specific industrial problem, namely replacing formaldehyde-based binders in wood panel manufacturing. The trajectory is one of deliberate specialization — from enzyme technology provider to bio-based materials solution developer for the wood and furniture industry.
JENABIOS is moving from broad enzymatic chemistry toward application-specific bio-material solutions, suggesting future collaboration interest in sustainable adhesives, wood composites, or formaldehyde-free panel manufacturing.
JENABIOS has exclusively participated as a consortium partner, never leading a project, which positions them as a specialist contributor that brings a focused technical capability rather than project management infrastructure. With 20 unique partners across 8 countries in just 2 projects, they engage in medium-to-large consortia typical of BBI (Bio-based Industries) and bioeconomy research calls. This profile suggests they are comfortable operating within complex multi-partner structures where their enzyme or bio-chemistry expertise fills a defined slot.
JENABIOS has built a network of 20 unique consortium partners across 8 countries through only two projects — indicating dense, well-connected consortia rather than isolated bilateral collaboration. Their partnerships span European bioeconomy and bio-based materials research networks, though no specific geographic concentration is identifiable from the available data.
JENABIOS occupies a narrow but commercially relevant niche: they apply industrial enzyme chemistry to solve a real manufacturing problem — the wood panel industry's dependence on fossil-derived, often toxic binders like formaldehyde resins. Few SMEs combine wet biochemistry expertise with direct application knowledge in panel board manufacturing. For consortia working on bio-based chemicals, sustainable construction materials, or green adhesives, they offer a technically specific partner rather than a generalist biology lab.
